Myomo (MYO) Convertible Debt (2016)
Myomo's (MYO) quarterly Convertible Debt came in at $2.2 million in Q4 2016.
Myomo (MYO) Convertible Debt (2016) Analysis & Trends
Myomo (MYO) has 1 years of Convertible Debt data on file, last reported at $2.2 million in Q4 2016.
- Quarterly Convertible Debt changed N/A year-over-year to $2.2 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $2.2 million (changed N/A YoY) and the FY2016 annual result came in at $2.2 million, changed N/A from the prior year.
- Convertible Debt was little changed at $2.2 million in Q4 2016.
- In the past five years, Convertible Debt ranged from a high of $2.2 million in Q4 2016 to a low of $2.2 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.20 Mn |